Differential regulation of fat cell beta-2 and beta-1 adrenoceptors by endogenous catecholamines in dog
- PMID: 2540316
Differential regulation of fat cell beta-2 and beta-1 adrenoceptors by endogenous catecholamines in dog
Abstract
The effects of long-term endogenous catecholamine exposure on the regulation of leukocyte and adipocyte beta adrenoceptor subtypes were studied through an experimental model of chronic neurogenic hypertension in the dog. Chronic sinoaortic denervation (SAD) is associated with a significant increase in plasma catecholamine levels, a reduction in the total beta adrenoceptor number of the leukocytes (52%) as well as of the omental adipocytes (59%). Using highly selective beta antagonists (bisoprolol for beta-1; ICI 118,551 for beta-2 adrenoceptors) we demonstrate that the normal dog fat cell possess both beta-2 and beta-1 adrenoceptors in proportions of 67 and 33%, respectively. SAD-induced catecholamine enhancement promotes a strong reduction of beta-2 (but not beta-1) adrenoceptor number (from 237 +/- 28 to 52 +/- 13 fmol/mg of protein) leading to a new relative distribution in fat cell membranes: 36% for beta-2 and 64% for beta-1 adrenoceptors. Such a different regulation provokes major consequences in the associated-biological effect on adipocytes when evaluating the lipolytic process. Lipolysis induced by epinephrine or isoproterenol (two mixed agonists) is weakly but significantly reduced whereas lipolysis induced by procaterol (a highly selective beta-2 agonist) is strongly reduced. These data fit with the results of the binding studies and demonstrate the loss in beta-2 adrenoceptor number and efficiency in SAD dogs. The present study demonstrates a differential regulation of beta adrenoceptors: beta-2 but not beta-1 adrenoceptors are decreased by long-term exposure to high plasma levels of endogenous catecholamines in the dog.
Similar articles
-
Characterization of dog fat cell adrenoceptors: variations in alpha-2 and beta adrenergic receptors distribution according to the extent of the fat deposits and the anatomical location.J Pharmacol Exp Ther. 1987 Sep;242(3):1041-9. J Pharmacol Exp Ther. 1987. PMID: 2821223
-
Fat cell adrenoceptors: inter- and intraspecific differences and hormone regulation.Int J Obes. 1985;9 Suppl 1:117-27. Int J Obes. 1985. PMID: 2999011 Review.
-
Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.Am J Physiol. 1993 Mar;264(3 Pt 1):E403-12. doi: 10.1152/ajpendo.1993.264.3.E403. Am J Physiol. 1993. PMID: 8096365
-
[Renal adrenergic beta receptors and experimental neurogenic hypertension].Arch Mal Coeur Vaiss. 1991 Aug;84(8):1163-6. Arch Mal Coeur Vaiss. 1991. PMID: 1659344 French.
-
The beta-adrenergic system in man: physiological and pathophysiological response. Regulation of receptor density and functioning.Scand J Clin Lab Invest Suppl. 1990;201:25-43. Scand J Clin Lab Invest Suppl. 1990. PMID: 1978755 Review.
Cited by
-
Myocardial hypertrophy, cardiac beta-adrenoceptors and adenylate cyclase activity during sinoaortic denervation in dogs.Br J Pharmacol. 1992 Feb;105(2):341-6. doi: 10.1111/j.1476-5381.1992.tb14256.x. Br J Pharmacol. 1992. PMID: 1313724 Free PMC article.
-
Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs.Br J Pharmacol. 1992 Jan;105(1):181-3. doi: 10.1111/j.1476-5381.1992.tb14232.x. Br J Pharmacol. 1992. PMID: 1596679 Free PMC article.
-
Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.J Clin Invest. 1990 Jan;85(1):291-5. doi: 10.1172/JCI114425. J Clin Invest. 1990. PMID: 2104880 Free PMC article.
-
Is neuropeptide Y co-released with catecholamines in experimental arterial hypertension following sinoaortic denervation?Naunyn Schmiedebergs Arch Pharmacol. 1992 Apr;345(4):431-6. doi: 10.1007/BF00176621. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1620243
-
Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.J Clin Invest. 1992 Dec;90(6):2175-86. doi: 10.1172/JCI116103. J Clin Invest. 1992. PMID: 1334970 Free PMC article.